143 related articles for article (PubMed ID: 30464713)
1. PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.
Zumárraga JP; Batista FAR; Baptista AM; Caiero MT; Martino LPR; de Camargo OP
Acta Ortop Bras; 2018; 26(5):320-324. PubMed ID: 30464713
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
Odei B; Rwigema JC; Eilber FR; Eilber FC; Selch M; Singh A; Chmielowski B; Nelson SD; Wang PC; Steinberg M; Kamrava M
Am J Clin Oncol; 2018 Sep; 41(9):827-831. PubMed ID: 28640064
[TBL] [Abstract][Full Text] [Related]
4. Localized Myxofibrosarcoma: A Retrospective Analysis of Primary Therapy and Prognostic Factors in 134 Patients in a Single Institution.
Pogkas A; Reichardt P; Tunn PU; Niethard M; Werner M; Ghani S
Oncologist; 2024 Apr; 29(4):e544-e552. PubMed ID: 38141181
[TBL] [Abstract][Full Text] [Related]
5. PRIMARY LEIOMYOSARCOMA OF BONE: CLINICOPATHOLOGIC AND PROGNOSTIC FACTORS ANALYSIS IN A SINGLE INSTITUTION.
Zumárraga JP; Arouca MM; Baptista AM; Caiero MT; Rubio DE; de Camargo OP
Acta Ortop Bras; 2019; 27(3):152-155. PubMed ID: 31452611
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort.
Radaelli S; Pasquali S; Colombo C; Callegaro D; Sanfilippo R; Stacchiotti S; Provenzano S; Sangalli C; Morosi C; Barisella M; Miceli R; Fiore M; Gronchi A
Eur J Surg Oncol; 2022 Aug; 48(8):1723-1729. PubMed ID: 35153104
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
Chen W; Ye M; Sun Y; Wei Y; Huang Y
Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
[TBL] [Abstract][Full Text] [Related]
9. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and outcomes of patients with myxofibrosarcoma.
Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
[TBL] [Abstract][Full Text] [Related]
11. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors in 171 patients with myxofibrosarcoma of the trunk and extremities: a cohort study.
Liu H; Zhang X; Zhang S; Yu S
Ann Transl Med; 2021 Aug; 9(16):1322. PubMed ID: 34532459
[TBL] [Abstract][Full Text] [Related]
13. Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma.
Haglund KE; Raut CP; Nascimento AF; Wang Q; George S; Baldini EH
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):361-7. PubMed ID: 20951504
[TBL] [Abstract][Full Text] [Related]
14. Oncological Outcomes in Patients with Appendicular Myxofibrosarcomas: A Retrospective Study.
Lee Y; Guertin MP; Summers S; Conway SA; Al Maaieh M; Yechieli R; Trent J; Rosenberg AE; Pretell-Mazzini J
J Oncol; 2021; 2021():1844816. PubMed ID: 34876901
[TBL] [Abstract][Full Text] [Related]
15. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
16. MRI Features as Prognostic Factors in Myxofibrosarcoma: Proposal of MRI Grading System.
Spinnato P; Clinca R; Vara G; Cesari M; Ponti F; Facchini G; Longhi A; Donati DM; Bianchi G; Sambri A
Acad Radiol; 2021 Nov; 28(11):1524-1529. PubMed ID: 32928636
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
[TBL] [Abstract][Full Text] [Related]
18. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
19. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype?
Dadrass F; Gusho C; Yang F; Culvern C; Bloom J; Fillingham Y; Colman M; Gitelis S; Blank A
J Surg Oncol; 2021 Feb; 123(2):489-496. PubMed ID: 33125727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
